{"id":57835,"date":"2026-02-24T18:17:07","date_gmt":"2026-02-24T10:17:07","guid":{"rendered":"https:\/\/flcube.com\/?p=57835"},"modified":"2026-02-24T18:17:08","modified_gmt":"2026-02-24T10:17:08","slug":"yoltech-partners-with-xtalpi-to-build-ai-driven-mrna-and-car-t-screening-platform-closed-loop-dry-wet-lab-integration","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=57835","title":{"rendered":"YolTech Partners with XtalPi to Build AI\u2011Driven mRNA and CAR\u2011T Screening Platform \u2013 Closed\u2011Loop Dry\u2011Wet Lab Integration"},"content":{"rendered":"\n<p><strong>YolTech Therapeutics<\/strong>, a China\u2011based <strong>mRNA therapy and gene therapy developer<\/strong>, announced a strategic partnership with <strong>XtalPi Inc. (<a href=\"https:\/\/www.google.com\/finance\/quote\/2228:HKG\">HKG:\u202f2228<\/a>)<\/strong>, a Sino\u2011US <strong>artificial intelligence (AI)<\/strong> firm. The collaboration aims to build an <strong>AI\u2011driven closed\u2011loop screening platform<\/strong> integrating <strong>dry lab (computational)<\/strong> and <strong>wet lab (experimental)<\/strong> capabilities to accelerate breakthrough therapies, with initial focus on <strong>mRNA drugs<\/strong> and <strong>CAR\u2011T therapy<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-partnership-overview\">Partnership Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Partner 1<\/strong><\/td><td>YolTech Therapeutics (mRNA\/gene therapy developer)<\/td><\/tr><tr><td><strong>Partner 2<\/strong><\/td><td>XtalPi Inc. (HKG:\u202f2228) \u2013 AI\u2011driven drug discovery platform<\/td><\/tr><tr><td><strong>Collaboration Type<\/strong><\/td><td>Strategic R&amp;D partnership<\/td><\/tr><tr><td><strong>Platform Objective<\/strong><\/td><td>AI\u2011driven closed\u2011loop screening platform<\/td><\/tr><tr><td><strong>Integration Model<\/strong><\/td><td>Dry lab (computational) + Wet lab (experimental)<\/td><\/tr><tr><td><strong>Therapeutic Focus<\/strong><\/td><td>mRNA drugs and CAR\u2011T therapy<\/td><\/tr><tr><td><strong>Geography<\/strong><\/td><td>China\u2011based collaboration with global AI capabilities<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-platform-workflow-closed-loop-iteration\">Platform Workflow \u2013 Closed\u2011Loop Iteration<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Stage<\/th><th>Responsibility<\/th><th>Activity<\/th><\/tr><\/thead><tbody><tr><td><strong>1. Target Input<\/strong><\/td><td>YolTech<\/td><td>Provide target information and biological specifications<\/td><\/tr><tr><td><strong>2. AI Optimization<\/strong><\/td><td>XtalPi<\/td><td>Global mRNA sequence optimization for expression efficiency, stability, and duration of effect<\/td><\/tr><tr><td><strong>3. Sequence Output<\/strong><\/td><td>XtalPi<\/td><td>Deliver optimal candidate sequence library<\/td><\/tr><tr><td><strong>4. Synthesis &amp; Delivery<\/strong><\/td><td>YolTech<\/td><td>Rapid preparation using proprietary mRNA synthesis and LNP platform<\/td><\/tr><tr><td><strong>5. Experimental Validation<\/strong><\/td><td>YolTech<\/td><td>In vitro cellular and in vivo animal studies; evaluate druggability and biological function<\/td><\/tr><tr><td><strong>6. Data Feedback<\/strong><\/td><td>YolTech<\/td><td>Generate high\u2011quality, standardized validation data<\/td><\/tr><tr><td><strong>7. Model Refinement<\/strong><\/td><td>XtalPi<\/td><td>Integrate experimental data to refine AI algorithms<\/td><\/tr><tr><td><strong>8. Iterative Cycle<\/strong><\/td><td>Both<\/td><td>Continuous improvement loop for enhanced prediction accuracy<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\">Strategic Rationale<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>AI\u2011Accelerated Discovery:<\/strong> The partnership leverages <strong>XtalPi&#8217;s computational physics and AI capabilities<\/strong> to dramatically reduce the time and cost of mRNA sequence optimization, traditionally a labor\u2011intensive process.<\/li>\n\n\n\n<li><strong>Wet Lab Validation:<\/strong> YolTech&#8217;s <strong>proprietary mRNA synthesis and LNP delivery platform<\/strong> provides rapid experimental validation, generating real\u2011world data to train and refine AI models\u2014creating a <strong>virtuous cycle of improvement<\/strong>.<\/li>\n\n\n\n<li><strong>Dual Therapeutic Focus:<\/strong> Initial applications in <strong>mRNA therapeutics<\/strong> (vaccines, protein replacement, gene editing) and <strong>CAR\u2011T cell therapy<\/strong> (genetic modification, persistence enhancement) address high\u2011growth segments with significant unmet medical need.<\/li>\n\n\n\n<li><strong>Competitive Differentiation:<\/strong> The <strong>closed\u2011loop integration<\/strong> of computational prediction and experimental validation differentiates the platform from siloed AI\u2011only or wet\u2011lab\u2011only approaches, potentially accelerating time\u2011to\u2011clinic.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-components\">Technology Components<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Provider<\/th><th>Capability<\/th><\/tr><\/thead><tbody><tr><td><strong>AI\/ML Platform<\/strong><\/td><td>XtalPi<\/td><td>Multi\u2011objective sequence optimization; predictive modeling<\/td><\/tr><tr><td><strong>mRNA Synthesis<\/strong><\/td><td>YolTech<\/td><td>Rapid, scalable production of optimized sequences<\/td><\/tr><tr><td><strong>LNP Delivery<\/strong><\/td><td>YolTech<\/td><td>Proprietary lipid nanoparticle formulation for efficient cellular delivery<\/td><\/tr><tr><td><strong>Validation Pipeline<\/strong><\/td><td>YolTech<\/td><td>Standardized in vitro\/in vivo assessment protocols<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact\">Market Impact<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>China AI\u2011Drug Discovery Trend:<\/strong> The partnership exemplifies the <strong>accelerating convergence<\/strong> of Chinese biotech and domestic AI capabilities, positioning both companies at the forefront of next\u2011generation therapeutic development.<\/li>\n\n\n\n<li><strong>mRNA Market Expansion:<\/strong> The global mRNA therapeutics market is projected to exceed <strong>$50\u202fbillion<\/strong> by 2030, with AI\u2011driven optimization enabling novel applications beyond vaccines.<\/li>\n\n\n\n<li><strong>CAR\u2011T Innovation:<\/strong> AI\u2011guided genetic modifications could address <strong>CAR\u2011T persistence and efficacy challenges<\/strong>, unlocking solid tumor applications and reducing manufacturing costs.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding platform development timelines, therapeutic candidate advancement, and commercial potential. Actual results may differ due to risks including technology integration challenges, experimental validation outcomes, and competitive dynamics in AI\u2011driven drug discovery.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>YolTech Therapeutics, a China\u2011based mRNA therapy and gene therapy developer, announced a strategic partnership with&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[99,21,77,1112,63,696,1168],"class_list":["post-57835","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-ai","tag-car-t","tag-cell-therapy","tag-hkg-2228","tag-mrna","tag-xtalpi","tag-yoltech-therapeutics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>YolTech Partners with XtalPi to Build AI\u2011Driven mRNA and CAR\u2011T Screening Platform \u2013 Closed\u2011Loop Dry\u2011Wet Lab Integration - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"YolTech Therapeutics, a China\u2011based mRNA therapy and gene therapy developer, announced a strategic partnership with XtalPi Inc. (HKG:\u202f2228), a Sino\u2011US artificial intelligence (AI) firm. The collaboration aims to build an AI\u2011driven closed\u2011loop screening platform integrating dry lab (computational) and wet lab (experimental) capabilities to accelerate breakthrough therapies, with initial focus on mRNA drugs and CAR\u2011T therapy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=57835\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"YolTech Partners with XtalPi to Build AI\u2011Driven mRNA and CAR\u2011T Screening Platform \u2013 Closed\u2011Loop Dry\u2011Wet Lab Integration\" \/>\n<meta property=\"og:description\" content=\"YolTech Therapeutics, a China\u2011based mRNA therapy and gene therapy developer, announced a strategic partnership with XtalPi Inc. (HKG:\u202f2228), a Sino\u2011US artificial intelligence (AI) firm. The collaboration aims to build an AI\u2011driven closed\u2011loop screening platform integrating dry lab (computational) and wet lab (experimental) capabilities to accelerate breakthrough therapies, with initial focus on mRNA drugs and CAR\u2011T therapy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=57835\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-24T10:17:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T10:17:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57835#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57835\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"YolTech Partners with XtalPi to Build AI\u2011Driven mRNA and CAR\u2011T Screening Platform \u2013 Closed\u2011Loop Dry\u2011Wet Lab Integration\",\"datePublished\":\"2026-02-24T10:17:07+00:00\",\"dateModified\":\"2026-02-24T10:17:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57835\"},\"wordCount\":528,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"AI\",\"CAR-T\",\"Cell-therapy\",\"HKG: 2228\",\"mRNA\",\"Xtalpi\",\"YolTech Therapeutics\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=57835#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57835\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=57835\",\"name\":\"YolTech Partners with XtalPi to Build AI\u2011Driven mRNA and CAR\u2011T Screening Platform \u2013 Closed\u2011Loop Dry\u2011Wet Lab Integration - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-02-24T10:17:07+00:00\",\"dateModified\":\"2026-02-24T10:17:08+00:00\",\"description\":\"YolTech Therapeutics, a China\u2011based mRNA therapy and gene therapy developer, announced a strategic partnership with XtalPi Inc. (HKG:\u202f2228), a Sino\u2011US artificial intelligence (AI) firm. The collaboration aims to build an AI\u2011driven closed\u2011loop screening platform integrating dry lab (computational) and wet lab (experimental) capabilities to accelerate breakthrough therapies, with initial focus on mRNA drugs and CAR\u2011T therapy.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57835#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=57835\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57835#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"YolTech Partners with XtalPi to Build AI\u2011Driven mRNA and CAR\u2011T Screening Platform \u2013 Closed\u2011Loop Dry\u2011Wet Lab Integration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"YolTech Partners with XtalPi to Build AI\u2011Driven mRNA and CAR\u2011T Screening Platform \u2013 Closed\u2011Loop Dry\u2011Wet Lab Integration - Insight, China&#039;s Pharmaceutical Industry","description":"YolTech Therapeutics, a China\u2011based mRNA therapy and gene therapy developer, announced a strategic partnership with XtalPi Inc. (HKG:\u202f2228), a Sino\u2011US artificial intelligence (AI) firm. The collaboration aims to build an AI\u2011driven closed\u2011loop screening platform integrating dry lab (computational) and wet lab (experimental) capabilities to accelerate breakthrough therapies, with initial focus on mRNA drugs and CAR\u2011T therapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=57835","og_locale":"en_US","og_type":"article","og_title":"YolTech Partners with XtalPi to Build AI\u2011Driven mRNA and CAR\u2011T Screening Platform \u2013 Closed\u2011Loop Dry\u2011Wet Lab Integration","og_description":"YolTech Therapeutics, a China\u2011based mRNA therapy and gene therapy developer, announced a strategic partnership with XtalPi Inc. (HKG:\u202f2228), a Sino\u2011US artificial intelligence (AI) firm. The collaboration aims to build an AI\u2011driven closed\u2011loop screening platform integrating dry lab (computational) and wet lab (experimental) capabilities to accelerate breakthrough therapies, with initial focus on mRNA drugs and CAR\u2011T therapy.","og_url":"https:\/\/flcube.com\/?p=57835","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-02-24T10:17:07+00:00","article_modified_time":"2026-02-24T10:17:08+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=57835#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=57835"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"YolTech Partners with XtalPi to Build AI\u2011Driven mRNA and CAR\u2011T Screening Platform \u2013 Closed\u2011Loop Dry\u2011Wet Lab Integration","datePublished":"2026-02-24T10:17:07+00:00","dateModified":"2026-02-24T10:17:08+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=57835"},"wordCount":528,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["AI","CAR-T","Cell-therapy","HKG: 2228","mRNA","Xtalpi","YolTech Therapeutics"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=57835#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=57835","url":"https:\/\/flcube.com\/?p=57835","name":"YolTech Partners with XtalPi to Build AI\u2011Driven mRNA and CAR\u2011T Screening Platform \u2013 Closed\u2011Loop Dry\u2011Wet Lab Integration - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-02-24T10:17:07+00:00","dateModified":"2026-02-24T10:17:08+00:00","description":"YolTech Therapeutics, a China\u2011based mRNA therapy and gene therapy developer, announced a strategic partnership with XtalPi Inc. (HKG:\u202f2228), a Sino\u2011US artificial intelligence (AI) firm. The collaboration aims to build an AI\u2011driven closed\u2011loop screening platform integrating dry lab (computational) and wet lab (experimental) capabilities to accelerate breakthrough therapies, with initial focus on mRNA drugs and CAR\u2011T therapy.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=57835#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=57835"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=57835#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"YolTech Partners with XtalPi to Build AI\u2011Driven mRNA and CAR\u2011T Screening Platform \u2013 Closed\u2011Loop Dry\u2011Wet Lab Integration"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=57835"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57835\/revisions"}],"predecessor-version":[{"id":57850,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57835\/revisions\/57850"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=57835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=57835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=57835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}